Salidroside protects against diabetes-induced cardiac dysfunction by modulating the mechanistic target of rapamycin (mTOR), AMPK, and AKT/heme oxygenase-1(HO-1) signaling pathways (Hao et al., 2021; Ni et al., 2021), (Table 4). This evidence concerns the gene HMOX1 and diabetes mellitus.